Skip to content

Trilogy Evo Universal

by Respironics, Inc.

510(k) K181170

Trilogy Evo Universal is a medical device (FDA Class II; FDA product code CBK, Ventilator, Continuous, Facility Use) made by Respironics, Inc., cleared under FDA 510(k) K181170 on 18 Jul 2019, active as of 22 Oct 2026. 11 FDA recalls are linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

13 ongoing

This device is named in the recall

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK181170 Date18 Jul 2019ClearedStatusActive

Official records

From the FDA record

Received by the FDA
2 May 2018
FDA decision
18 Jul 2019 (Substantially Equivalent)
FDA review time
442 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K181170 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

13 recalls · 13 ongoing · FDA

    • Ongoing Z-1617-2026 FDA Class I initiated 2 Mar 2026

    Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.

    • Ongoing Z-1649-2026 FDA Class I initiated 2 Mar 2026

    In some situations, the Obstruction Alarm does not trigger within the timeframe dictated by the relevant standards and may take up to four breaths.

    • Ongoing Z-0292-2025 FDA Class I initiated 7 Oct 2024

    Potential for in-line nebulizer configuration in certain locations to result in aerosol deposit accumulation on the device's internal flow sensor, which could lead to inaccurate flow measurements.

  • 3 recalls, same reason

    • Ongoing Z-2943-2024 FDA Class I initiated 16 Jul 2024
    • Ongoing Z-2944-2024 FDA Class I initiated 16 Jul 2024 on shared 510(k) K181170
    • Ongoing Z-2942-2024 FDA Class I initiated 16 Jul 2024 on shared 510(k) K181170

    Firm has released a mandatory software update Version 1.05.10.00 and a User Manual addendum for affected ventilators. These updates resolve safety issues identified in earlier recalls.

  • 2 recalls, same reason

    • Ongoing Z-1504-2024 FDA Class I initiated 19 Mar 2024
    • Ongoing Z-1505-2024 FDA Class I initiated 19 Mar 2024

    Potential for sudden loss of ventilation due to Battery Depleted or Loss of Power alarm while unit has sufficient power.

    • Ongoing Z-1652-2023 FDA Class I initiated 1 May 2023

    The Trilogy Evo Universal ventilator provides continuous or intermittent positive pressure ventilation for the care of individuals who require mechanical ventilation. Trilogy Evo Universal is intended for pediatric through adult patients weighing at least 2.5 kg. The ventilator can measure, display, record, and alarm SpO2, FiO2, CO2, and pulse rate data when integrated with the appropriate accessories. The ventilator is suitable for use in institutional and hospital settings and non-emergency transport settings; for example, wheelchair. It may be used for both invasive and non-invasive ventilation.

    • Ongoing Z-1289-2023 FDA Class I initiated 1 Mar 2023

    The accuracy of delivered oxygen may deviate below the required tolerance of 5% from setpoint when providing high concentration oxygen therapy. Additionally, if equipped, the internal FiO2 sensor may indicate a value higher than the device is actually delivering. This may lead to under delivery of oxygen.

  • 2 recalls, same reason

    • Ongoing Z-0493-2022 FDA Class I initiated 22 Dec 2021
    • Ongoing Z-0494-2022 FDA Class I initiated 22 Dec 2021

    Philips has identified a specific lot of non-conforming material manufactured by one of its suppliers. A Philips supplier incorrectly used polyester-based polyurethane (PE-PUR) sound abatement foam, a non-conforming material in the devices and repair kits. PE-PUR foam may degrade into particles which may enter the device s air pathway and be ingested or inhaled by the user. The foam degradation may be exacerbated by use of unapproved cleaning methods such as unapproved ozone cleaners, and the PE-PUR foam may off-gas certain chemicals during initial use of the device.

    • Ongoing Z-2290-2021 FDA Class II initiated 26 Jul 2021

    Two software issues have been identified related to pressure increase in the device: The first issue is described as "Infant/Pediatric EFS Calibration Pressure Increase" and the second issue is described as "Pressure Drift (Continuous Usage).

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Timeline

14 dated events

  1. Recall initiated FDA recalls Z-1289-2023
  2. Recall initiated FDA recalls Z-1652-2023
  3. Recall initiated FDA recalls Z-1504-2024
  4. Recall initiated FDA recalls Z-1505-2024
  5. Recall initiated FDA recalls Z-2943-2024
  6. Recall initiated FDA recalls Z-2944-2024
  7. Recall initiated FDA recalls Z-2942-2024
  8. Recall initiated FDA recalls Z-0292-2025
  9. Recall initiated FDA recalls Z-1617-2026
  10. Recall initiated FDA recalls Z-1649-2026

4 earlier events are in the sections above.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
CBK
Device class
Class II
Regulation
21 CFR Part 868.5895
Advisory committee
Anesthesiology
FDA decision
SESE Substantially Equivalent

Devices cleared under K181170

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K181170
UDI-DISize and differences
Trilogy Evo Universal DS2000X11B
Respironics Inc.
DS2000X11B / DS2000X11B00606959052000 —On the market

Similar devices

Other devices filed under FDA product code CBK (Ventilator, Continuous, Facility Use).

Other devices from Respironics, Inc.

See all devices from Respironics, Inc. →